Optinose Announces Reporting Date for Third Quarter 2022

YARDLEY, Pa., Nov. 07, 2022 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical firm targeted on sufferers handled by ear, nostril and throat (ENT) and allergy specialists, right now introduced the Company will report monetary outcomes for the third quarter 2022 and company updates, earlier than market open on Thursday, November 10, 2022.

Company to Host Conference Call
Members of the Company’s management workforce will host a convention name to debate monetary outcomes and company updates. The name is scheduled to begin at 8:00 a.m. Eastern Time on Thursday, November 10, 2022.

Participants might entry the convention name reside through webcast by visiting the Investors part of Optinose’s web site at http://ir.optinose.com/presentations. To take part through phone, please register prematurely at this hyperlink. Upon registration, all phone individuals will obtain a affirmation electronic mail detailing be a part of the convention name, together with the dial-in quantity and a private PIN that can be utilized to entry the decision. In addition, a replay of the webcast shall be out there on the Company web site for 60 days following the occasion.

About Optinose
Optinose is a world specialty pharmaceutical firm targeted on serving the wants of sufferers cared for by ear, nostril and throat (ENT) and allergy specialists. To be taught extra, please go to www.optinose.com or observe us on Twitter and LinkedIn.

Optinose Investor Contact
Jonathan Neely
[email protected]
267.521.0531